SCHEMBL6137746

SCHEMBL6137746

O=C1Nc2ccc(Cl)cc2C2CCCC12F

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 3/20 0.55
NOS1 P29475 3/20 0.55
NOS2 P35228 3/20 0.55
MAPT P10636 3/20 0.40
TP53 P04637 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
ALOX15 P16050 1/20 0.40
TSHR P16473 1/20 0.40
CASP1 P29466 1/20 0.40
CYP2C19 P33261 1/20 0.40
RECQL P46063 1/20 0.40
SLC8B1 Q6J4K2 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
PGR P06401 4/20 0.39
PDE7A Q13946 1/20 0.36
AHR P35869 1/20 0.36
MDM2 Q00987 1/20 0.35
CHEK1 O14757 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6137624 0.83 NOS3 (0.52) NOS3NOS1NOS2MAPTTP53
SCHEMBL6137467 0.83 POLB (0.43) NOS3NOS1NOS2MAPTTP53
SCHEMBL6137634 0.80 NOS3 (0.48) NOS3NOS1NOS2MEN1KMT2A
SCHEMBL7171088 0.72 HTT (0.37) NOS3NOS1NOS2CYP1A2CYP2C9
SCHEMBL6137774 0.72 NOS3 (0.39) NOS3NOS1NOS2CYP2C19
SCHEMBL6137320 0.71 NOS3 (1.00) NOS3NOS1NOS2
SCHEMBL6137525 0.70 NOS3 (0.41) NOS3NOS1NOS2CYP2C19
SCHEMBL6137662 0.69 NOS3 (0.34) NOS3NOS1NOS2MAPTTP53
SCHEMBL6137625 0.69 NOS3 (0.40) NOS3NOS1NOS2CHEK1
SCHEMBL6137677 0.68 TDP2 (0.39) NOS3NOS1NOS2RECQLPGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1129077-B9 FLUORINATED 3,4-DIHYDROQUINOLINE DERIVATIVES USED AS NOS INHIBITORS SCHERING AG (DE) 2005-07-20 EP disclosed
EP-1129077-B1 FLUORINATED 3,4-DIHYDROQUINOLINE DERIVATIVES USED AS NOS INHIBITORS SCHERING AG (DE) 2005-04-20 EP disclosed
US-6579883-B1 Nitrogen monoxide synthases; 4-amino-8-bromo-3a-fluoro-2,3,3a,9b-tetrahydro-1H-cyclopenta (c) quinoline; neurodegenerative, autoimmune, cardiovascular diseases SCHERING AKTIENGESELLSCHAFT (DE) 2003-06-17 US disclosed
EP-1129077-A1 FLUORINATED 3,4-DIHYDROQUINOLINE DERIVATIVES USED AS NOS INHIBITORS SCHERING AKTIENGESELLSCHAFT (DE) 2001-09-05 EP disclosed
WO-2000029381-A1 FLUORINATED 3,4-DIHYDROQUINOLINE DERIVATIVES USED AS NOS INHIBITORS SCHERING AKTIENGESELLSCHAFT (DE) 2000-05-25 WO disclosed